Clinical and Radiographic Response of Extramedullary Leukemia in Patients Treated With Gemtuzumab Ozogamicin
Authors:
- 1 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 41 (3) , e174-e176
Abstract
Extramedullary leukemia (EML) is common in pediatric acute leukemia and can present at diagnosis or relapse. CD33 is detected on the surface of myeloid blasts in many patients with acute myelogenous leukemia and is the target of the antibody drug conjugate gemtuzumab ozogamicin (GO). Here we present 2 patients with CD33+ EML treated with GO. They achieved significant response, with reduction of EML on both clinical and radiographic exams, specifically 18fluorine fluorodeoxyglucose positron emission tomography/computed tomography, demonstrating potential for targeted therapy with GO as a means of treating EML in patients with CD33+ leukemia and the utility of 18fluorine fluorodeoxyglucose positron emission tomography/computed tomography monitoring in EML.Keywords
This publication has 19 references indexed in Scilit:
- Extramedullary leukemia in children with acute myeloid leukemia: A population‐based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO)Pediatric Blood & Cancer, 2017
- Utility of FDG PET/CT in the Assessment of Myeloid SarcomaAmerican Journal of Roentgenology, 2012
- Radiation Therapy for Chloroma (Granulocytic Sarcoma)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- 18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemiaHaematologica, 2011
- Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2011
- Radiologic Spectrum of Extramedullary Relapse of Myelogenous Leukemia in AdultsAmerican Journal of Roentgenology, 2007
- Granulocytic sarcoma: 32 cases and review of the literatureLeukemia & Lymphoma, 2006
- Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrenceCancer, 2005
- Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemiaLeukemia, 2001
- Leukemia CutisDermatologic Clinics, 1994